{"id":"cyclosporin-low-dose-steroid","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Infections"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Gingival hyperplasia"}]},"_chembl":{"chemblId":"CHEMBL2108580","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cyclosporin is a calcineurin inhibitor that blocks T-cell receptor signaling and IL-2 production, preventing T-cell proliferation and activation. The addition of low-dose corticosteroids enhances immunosuppression through glucocorticoid receptor-mediated suppression of inflammatory cytokines and immune cell trafficking. This combination approach aims to achieve therapeutic immunosuppression while minimizing steroid-related toxicity through dose reduction.","oneSentence":"Cyclosporin suppresses T-cell activation and cytokine production, while low-dose steroids provide additional anti-inflammatory effects to reduce immune-mediated tissue damage.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:15.125Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Autoimmune or inflammatory conditions requiring immunosuppression (specific indication not publicly detailed for this Phase 3 trial)"}]},"trialDetails":[{"nctId":"NCT01282073","phase":"PHASE3","title":"Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2011-03","conditions":"Glomerulonephritis, Membranous","enrollment":43},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT01976390","phase":"NA","title":"Comparing Everolimus and Sirolimus in Renal Transplant Recipients","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2013-10-01","conditions":"Renal Failure","enrollment":60},{"nctId":"NCT00579527","phase":"PHASE1, PHASE2","title":"Phase I/II Thymus Transplantation With Immunosuppression #950","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2005-12-19","conditions":"DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly","enrollment":14},{"nctId":"NCT01062555","phase":"PHASE1, PHASE2","title":"Calcineurin Inhibitor Sparing After Kidney Transplantation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2006-10-01","conditions":"CNI Side Effects","enrollment":527},{"nctId":"NCT04540926","phase":"PHASE1, PHASE2","title":"Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2020-09","conditions":"COVID 19 Pneumonia","enrollment":200},{"nctId":"NCT03170323","phase":"PHASE4","title":"Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2018-07-01","conditions":"Idiopathic Membranous Nephropathy","enrollment":128},{"nctId":"NCT00074490","phase":"PHASE2","title":"Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-01-01","conditions":"Lymphoma, Leukemia, Myeloproliferative Disorders","enrollment":442},{"nctId":"NCT00154284","phase":"PHASE3","title":"Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-07","conditions":"Organ Transplantation, Renal Transplantation","enrollment":114},{"nctId":"NCT00281879","phase":"PHASE2","title":"Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2006-02","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":200},{"nctId":"NCT01410448","phase":"PHASE3","title":"Everolimus in de Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-11","conditions":"Kidney Transplantation","enrollment":383},{"nctId":"NCT00075478","phase":"PHASE3","title":"Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2003-10","conditions":"Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma","enrollment":87},{"nctId":"NCT00023244","phase":"PHASE2","title":"Steroid Withdrawal in Pediatric Kidney Transplant Recipients","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-01","conditions":"End-Stage Renal Disease","enrollment":274},{"nctId":"NCT01023815","phase":"PHASE3","title":"Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-04","conditions":"de Novo Kidney Transplant Recipients, Renal Transplantation","enrollment":330},{"nctId":"NCT02314312","phase":"PHASE3","title":"Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2012-01","conditions":"Transplantation of Kidney, Expanded Criteria Donor, ECD","enrollment":48},{"nctId":"NCT01817322","phase":"PHASE4","title":"Kidney Graft Function Under the Immunosuppression Strategies","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2011-06","conditions":"Chronic Renal Disease","enrollment":140},{"nctId":"NCT01596062","phase":"PHASE2","title":"Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-03","conditions":"Renal Transplantation","enrollment":16},{"nctId":"NCT01706471","phase":"PHASE4","title":"Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-06","conditions":"Planned Kidney Transplantation","enrollment":60},{"nctId":"NCT00806598","phase":"PHASE2","title":"Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-05","conditions":"Myelodysplastic Syndrome, Aplastic Anemia","enrollment":53},{"nctId":"NCT00833495","phase":"PHASE2","title":"Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation","status":"COMPLETED","sponsor":"Fovea Pharmaceuticals SA","startDate":"2009-01","conditions":"Allergic Conjunctivitis","enrollment":155},{"nctId":"NCT01023542","phase":"PHASE2, PHASE3","title":"CNI-free \"Bottom\"-up Immunosuppression in Patients Undergoing Liver Transplantation","status":"UNKNOWN","sponsor":"University of Regensburg","startDate":"2011-06","conditions":"Renal Impairment, Liver Transplantation, Everolimus","enrollment":45},{"nctId":"NCT00251004","phase":"PHASE3","title":"Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-10","conditions":"Kidney Transplantation, Graft Rejection","enrollment":833},{"nctId":"NCT00695344","phase":"PHASE4","title":"Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant","status":"UNKNOWN","sponsor":"Fundacion Investigacion y Desarrollo","startDate":"2006-01","conditions":"Cardiac Transplant","enrollment":52},{"nctId":"NCT00167947","phase":"PHASE3","title":"Study Evaluating Sirolimus in Kidney Transplant Recipients.","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-01","conditions":"Kidney Failure, Graft vs Host Disease","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":52,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Implanta soft capsule"],"phase":"phase_3","status":"active","brandName":"Cyclosporin, low dose steroid","genericName":"Cyclosporin, low dose steroid","companyName":"Kyungpook National University Hospital","companyId":"kyungpook-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cyclosporin suppresses T-cell activation and cytokine production, while low-dose steroids provide additional anti-inflammatory effects to reduce immune-mediated tissue damage. Used for Autoimmune or inflammatory conditions requiring immunosuppression (specific indication not publicly detailed for this Phase 3 trial).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}